Latest news
Citius Oncology Reports Strong Commercial Momentum for its Cancer Treatment - MorningstarMorningstar · Wed, 05 Aug 2026 13:36:59 GMTCitius Pharmaceuticals Stock Price Forecast. Should You Buy CTXR? - StockInvest.usStockInvest.us · Fri, 31 Jul 2026 22:26:23 GMTCitius Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:CTXR - TradingViewTradingView · Tue, 28 Jul 2026 17:51:44 GMTCitius Pharmaceuticals Inc (CTXR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKeyTradingKey · Tue, 28 Jul 2026 15:43:34 GMTCTXR|Citius Pharmaceuticals Inc|Price:0.625|Chg%:+0.056 - TradingKeyTradingKey · Mon, 27 Jul 2026 12:18:36 GMTCitius Pharmaceuticals Inc (CTXR) Financial Health: Profitability & Balance Sheet Analysis - TradingKeyTradingKey · Mon, 27 Jul 2026 00:03:06 GMTCitius Pharmaceuticals Inc (CTXR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKeyTradingKey · Sun, 26 Jul 2026 22:37:28 GMT